LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fiserv, Inc. (“Fiserv” or the “Company”) (NYSE: FI) common stock between July 24, 2024 and July 22, 2025, inclusive (the “Class Period”). Fiserv investors have until September 22, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR FISERV, IN.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming September 16, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NEOGEN INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO.

Criteo S.A. (NASDAQ:CRTO ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Melanie Dambre - Investor Relations Director Michael Komasinski - CEO & Director Sarah J.

Stifel Financial Corp. (NYSE:SF ) Q2 2025 Earnings Conference Call July 30, 2025 9:30 AM ET Company Participants James M. Marischen - Senior VP & CFO Joel Michael Jeffrey - Senior Vice President of Investor relations Ronald James Kruszewski - Chairman & CEO Conference Call Participants Alexander Blostein - Goldman Sachs Group, Inc., Research Division Devin Patrick Ryan - Citizens JMP Securities, LLC, Research Division Michael Cho - JPMorgan Chase & Co, Research Division Steven Joseph Chubak - Wolfe Research, LLC William Raymond Katz - TD Cowen, Research Division Operator Good day, and welcome to the Stifel Financial Second Quarter …

RSG tops second-quarter 2025 earnings estimates with strong margin gains, but the revenue miss and a lowered 2025 outlook weigh on results.

Although weak demand and tariffs cloud the Zacks Containers - Paper and Packaging industry's near-term outlook, BXBLY, ATR and GEF are navigating the challenges well.

New York, New York--(Newsfile Corp. - July 30, 2025) - IRAEmpire.com, a trusted resource for retirement investment research, has released a comprehensive report analyzing Lear Capital's gold and silver offerings, along with an in-depth look at its fees, pricing transparency, and customer value. Titled "Lear Capital Gold, Silver and Fees: What Investors Need to Know," the analysis dives into real customer feedback, pricing breakdowns, and competitive benchmarks across the precious metals IRA market.

Northwest Bancshares, Inc. (NASDAQ:NWBI ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Douglas M. Schosser - Chief Financial Officer Louis J.

I'm upgrading Palantir to "Buy" with a $165 price target, reflecting confidence in its AI leadership and expanding government and enterprise partnerships. Recent contracts, including Warp Speed for Warships and Maven Smart Systems, highlight Palantir's growing role in defense and federal digital transformation. Despite a lofty 128x price/sales valuation, I believe Palantir's operational momentum and resilient margins justify a premium relative to peers.

Allied Properties' Q2-2025 results show rising interest expenses and heavy property write-downs. Management's optimism on balance sheet progress is not supported by the numbers. The dangerously high debt-to-EBITDA ratio near 12x keeps sending warnings and that is not all.

Takeda Pharmaceutical Company Limited (NYSE:TAK ) Q1 FY2025 Earnings Call July 30, 2025 6:00 AM ET Company Participants Furuta - Corporate Participant O'Reilly - Corporate Participant Plump - Corporate Participant Weber - Corporate Participant Conference Call Participants Barker - Unidentified Company Kim - Unidentified Company Matsubara - Unidentified Company Muraoka - Unidentified Company Nedelcoyvch - Unidentified Company Ueda - Unidentified Company Wakao - Unidentified Company Yamaguchi - Unidentified Company O'Reilly [inaudible] joining us for FY2025 Q1 earnings announcement by Takeda despite your very busy schedule today. [inaudible] Head of IR.

Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Christopher J. Stevo - Senior Vice President of Investor Relations & Competitive Intelligence Eliyahu Sharon Kalif - Executive VP & CFO Eric A.

KHC tops Q2 estimates despite declines in earnings and organic sales, as pricing gains fail to offset weak volumes.

Teladoc Health remains a deep value play at $7, trading at just 5-6x EBITDA, but lacks a clear growth catalyst. Revenue and user metrics are declining across core segments, with BetterHelp and Chronic Care both losing momentum and failing to innovate. Recent acquisitions (UpLift, Catapult Health) have not meaningfully expanded Teladoc's platform or addressed its reliance on basic telehealth connections.

Chevron has been granted a restricted U.S. license to operate in sanctioned Venezuela, three sources close to the decision said on Wednesday, adding that no money from oil proceeds can be transferred in any way to the administration of Venezuelan President Nicolas Maduro.

Virtu Financial, Inc. (NYSE:VIRT ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Andrew Smith - Senior VP of Global Business Development & Corporate Strategy Cindy Lee - Executive VP, CFO & Treasurer Douglas A. Cifu - Co-founder, CEO & Director Joseph A.

VRSK posts 8.1% y/y EPS growth in second-quarter 2025, and lifts its revenue and EBITDA guidance despite a lowered EPS outlook.

NFLX, DIS and ROKU capitalize on streaming's global surge with content strength, platform growth and user engagement.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

As markets pull back on China tariff tension, DIS, TEL, FTNT, BBVA, and ON shine with high ROE and strong fundamentals.